Fundz

LifeMine Therapeutics Announces $50 Million Series B Financing

PRIVATEJan 07, 2021

Amount Raised

$50 Million

Round Type

Series B

CambridgeBiotechnologyHealthcareTherapeuticsBiopharma

Description

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining fungal biodiversity to develop mechanistically and structurally novel therapeutics, today announced a $50 million Series B financing from leading life sciences investors. The financing was led by Rick Klausner and Milky Way Investments, with participation from existing investors GV (formerly Google Ventures), WuXi Healthcare Ventures, Foresite Capital, Arch Ventures, Blue Pool Capital, and MRL Ventures Fund. Proceeds from the Series B financing will allow the Company to accelerate and expand its drug discovery efforts, as well as strategically advance select pipeline programs toward clinical development.

Quick answer

LifeMine Therapeutics raised $50 Million in a Series B round, dated January 7, 2021. LifeMine Therapeutics is based in Cambridge, Massachusetts, United States.

How much did LifeMine Therapeutics raise?
LifeMine Therapeutics raised $50 Million in a Series B round on January 7, 2021.
What does LifeMine Therapeutics do?
LifeMine Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™.
Where is LifeMine Therapeutics based and how big is it?
LifeMine Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 51 employees.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as LifeMine Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • ISOThrive raised $5.2M on February 5, 2021.
  • Terns Pharmaceuticals raised $98M on January 7, 2021.
  • Terns Pharmaceuticals raised $87M (Series C) on January 5, 2021.
  • Parabilis Medicines raised $23M on January 5, 2021.
  • OnKure Therapeutics, Inc. raised $47M on December 21, 2020.
  • Phio Pharmaceuticals raised $14M on February 16, 2021.

Who to call at LifeMine Therapeutics, and when

A new round usually means LifeMine Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LifeMine Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LifeMine Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LifeMine Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LifeMine Therapeutics

Location

100 Acorn Park, 6th Floor

Cambridge, Massachusetts, United States

About

LifeMine Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™. The company leverages digital genomic search technology from fungi to source next-generation precision medicines. They focus on developing therapies for transplantation and immunology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LifeMine Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for LifeMine Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

LifeMine Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.